COMMUNIQUÉS West-GlobeNewswire
-
Celldex Reports Results from Phase 2 Study of Barzolvolimab in Prurigo Nodularis
21/07/2026 -
Nurix Therapeutics Announces HSR Clearance of Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology
21/07/2026 -
Acquisition of Own Shares
21/07/2026 -
A Child's Light Announces Receipt of $6,500 Grant to Expedite Youth Mental Health Care
21/07/2026 -
NMDP Celebrates Bipartisan House Passage of Life-Saving Stem Cell Therapeutic and Research Reauthorization Act
21/07/2026 -
Summer Hair Restoration Promo Now Available at Cross Medical Group
21/07/2026 -
Coalition to Improve Access to Cancer Care Applauds Reintroduction of the Cancer Drug Parity Act
22/07/2026 -
Jushi Holdings Inc. to Report Second Quarter 2026 Financial Results on July 28, 2026
21/07/2026 -
TLX591-Tx ProstACT SELECT Study Published in Cancers Journal
21/07/2026 -
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
21/07/2026 -
OraSure Receives Emergency Use Authorization for Second Generation Ebola Test
21/07/2026 -
Dentsply Sirona to Host Second Quarter Conference Call on August 6th
21/07/2026 -
Blink Anesthesia Appoints Three New Board Members
21/07/2026 -
AiM Medical Robotics Appoints Startup Veteran Andrew Aberdale as President and Chief Financial Officer
21/07/2026 -
Frantz EyeCare Surpasses National Averages with Light Adjustable Lens, Delivering Industry-Leading Vision Outcomes
21/07/2026 -
Press Release: Sanofi evolves its Executive Committee to support its next strategic chapter
21/07/2026 -
Communiqué de presse : Sanofi fait évoluer son Comité exécutif pour préparer son prochain chapitre stratégique
21/07/2026 -
IPSEN - Buy-back programme - Art 5 of MAR - Week 29 - 2026
21/07/2026 -
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 29 - 2026
21/07/2026
Pages